Condition
Mycobacterium Avium Complex Pulmonary Disease
Total Trials
5
Recruiting
4
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 65/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
60%
3 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
4Total
P 2 (1)
P 4 (3)
Trial Status
Recruiting4
Terminated1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07213765Phase 4RecruitingPrimary
Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease
NCT07084402Phase 4RecruitingPrimary
Short-term Bactericidal Effect of Contezolid in MAC-PD
NCT07174076Phase 4RecruitingPrimary
Prevention of Recurrence With Cordyceps Sinensis in Mycobacterium Avium Complex Pulmonary Disease
NCT05861258Phase 2TerminatedPrimary
Pharmacokinetic Study of Minocycline in Patients With Pulmonary Nontuberculous Mycobacterial Disease
NCT05906316RecruitingPrimary
A Prospective, Multicenter, Single-arm MAC-PD Cohort: a NTM-NET and ESGMYC Collaborative Study
Showing all 5 trials